HC
PFE icon

Hawkins Capital’s Pfizer PFE Stock Holding History

Hawkins Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.41M Sell
41,106
-115,940
-74% -$3.95M 2.55% 17
2017
Q3 		$5.32M Hold
157,046
– – 2.2% 19
2017
Q2 		$5M Hold
157,046
– – 1.73% 24
2017
Q1 		$5.1M Hold
157,046
– – 1.63% 26
2016
Q4 		$4.84M Buy
157,046
+32,674
+26% +$997K 1.55% 27
2016
Q3 		$4M Hold
124,372
– – 1.28% 29
2016
Q2 		$4.15M Buy
+124,372
New +$3.97M 1.39% 27

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hawkins Capital's PFE Position: Q4 2017 in Review

Hawkins Capital reduced its Pfizer (PFE) stake by 74% in Q4 2017, selling an estimated $3.95M and leaving 41,106 shares worth $1.41M. The position accounts for 2.55% of the portfolio, ranked #17.

Hawkins Capital first reported a position in PFE in Q2 2016 and has held it in 7 quarters since. The position peaked at $5.32M in Q3 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Hawkins Capital held 41,106 shares of Pfizer worth $1.41M as of Q4 2017.
  • Hawkins Capital sold 115,940 Pfizer shares in Q4 2017, an estimated $3.95M.
  • Pfizer made up 2.55% of Hawkins Capital's portfolio in Q4 2017, its #17 holding.
  • Hawkins Capital first reported a position in Pfizer in Q2 2016 and has held it in 7 quarters since.
  • Hawkins Capital's Pfizer position peaked at $5.32M in Q3 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Hawkins Capital's 13F filing for Q4 2017, filed 12 Feb 2018.